Pneumococcal Conjugate Vaccine Impact on Meningitis and Pneumonia Among Children Aged  | Zendy

Vongai Dondo | Zendy; Hilda Mujuru | Zendy; Kusum Nathoo | Zendy; Vengai Jacha | Zendy; Ottias Tapfumanei | Zendy; Priscilla Chirisa | Zendy; Portia Manangazira | Zendy; John Macharaga | Zendy; Linda de Gouveia | Zendy; Jason M. Mwenda | Zendy; Regis Katsande | Zendy; Goitom Weldegebriel | Zendy; Tracy Pondo | Zendy; Almea Matanock | Zendy; Fernanda C. Lessa | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pneumococcal Conjugate Vaccine Impact on Meningitis and Pneumonia Among Children Aged <5 Years—Zimbabwe, 2010–2016

Author(s) -

Vongai Dondo,

Hilda Mujuru,

Kusum Nathoo,

Vengai Jacha,

Ottias Tapfumanei,

Priscilla Chirisa,

Portia Manangazira,

John Macharaga,

Linda de Gouveia,

Jason M. Mwenda,

Regis Katsande,

Goitom Weldegebriel,

Tracy Pondo,

Almea Matanock,

Fernanda C. Lessa

Publication year - 2019

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciz462

Subject(s) - medicine , pneumococcal conjugate vaccine , meningitis , streptococcus pneumoniae , pediatrics , pneumonia , antibiotics , microbiology and biotechnology , biology

Streptococcus pneumoniae is a leading cause of pneumonia and meningitis in children aged <5 years. Zimbabwe introduced 13-valent pneumococcal conjugate vaccine (PCV13) in 2012 using a 3-dose infant schedule with no booster dose or catch-up campaign. We evaluated the impact of PCV13 on pediatric pneumonia and meningitis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research